Felocell 4
Felocell 4 is a modified live vaccine comprising feline rhinotracheitis, calici, and panleukopenia viruses and Chlamydophila felis in a lyophilised form.
Expand All
-
Felocell 4 is for vaccination of healthy cats as an aid in preventing feline viral rhinotracheitis (FVR) caused by feline herpesvirus-1, feline respiratory disease caused by feline calicivirus (FCV), feline panleukopaenia (FPL) caused by feline parvovirus, and feline chlamydophilosis caused by Chlamydophila felis.
Felocell 4 contains attenuated strains of feline rhinotracheitis virus, calicivirus and panleukopaenia virus (Johnson Snow Leopard strain), and C. felis, propagated on established cell lines.
-
- Felocell 4 is well tolerated as demonstrated in laboratory tests and field trials involving cats ranging in age from 5 weeks to 17 years old. The majority of cats exhibited no serious post-vaccination reactions attributable to the vaccine1.
- Efficacy of Felocell 4 was determined by challenge-of-immunity tests. Vaccinated cats experienced significantly less severe clinical signs than non-vaccinated control cats after challenge with virulent FVR virus, FCV, FPL virus or C. felis1.
- Results of serological studies indicated that no immunological interference existed amoong the vaccine fractions. In specific pathogen-free cats, vaccination with Felocell 4 stimulated serological titres to each of the 4 vaccine fractions1.
-
Felocell 4 is packaged in freeze-dried form with inert gas in place of vacuum and available in packs of 25 x 1 mL dose vials of vaccine with diluent.
-
Vaccination of healthy cats is recommended. Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided, shake well and administer 1 mL subcutaneously or intramuscularly.
Primary vaccination: Healthy cats 12 weeks of age or older should receive 2 doses administered 3-4 weeks apart. Cats vaccinated at less than 12 weeks of age should be revaccinated at 12 weeks of age.
Revaccination: Annual revaccination with a single dose is recommended.
-
This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitised, are stressed due to shipment or environmental conditions, are otherwise immuno-compromised, or the vaccine is not administered in accordance with label directions.
- Store at 2-8ºC (Refrigerate, do not freeze). Prolonged exposure to higher temperatures may adversely affect potency.
- Use entire contents when first opened.
- Sterilised syringes and needles should be used to administer this vaccine. Do not sterilise with chemicals because traces of disinfectant may inactivate the vaccines.
- Burn containers and all unused contents.
- Contains gentamicin as preservative.
- Vaccination of pregnant queens should be avoided.
- The use of this product has been associated with fever, anorexia and lethargy in 1% of vaccinated cats, often occurring in clusters in association with multiple concurrent vaccinations. Veterinary intervention may be required. When treatment is necessary, supportive care, steroids and antibiotics have been utilised.
- As with many vaccines, anaphylaxis may occur following use. In this event, an initial antidote of adrenaline is recommended and should be followed by appropriate supportive therapy.
- In case of accidental human exposure, consult a physician.
Prescription Animal Remedy. Keep out of reach of children. For animal treatment only.
-
Zoetis Animal Health New Zealand Limited. Level 5, 8 Mahuhu Crescent, Auckland 1010, New Zealand. Tel: 0800 650 277, Fax: 0800 628 629. FELOCELL is a registered trade mark of Zoetis Inc. or its subsidiaries. ACVM Registration No. A5694. RVM; Available only under Veterinary Authorisation.
References:
- Felocell 4 ACVM approved label.
-
For technical enquiries please phone Zoetis Technical Services on 0800 650 277.
-
Cats
Antibiotics, parasite control and disease prevention for cats.